hydralazine has been researched along with Atrial Septal Defect in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolibash, AJ | 1 |
| Magorien, RD | 1 |
| Robinson, JL | 1 |
| Leier, CV | 1 |
1 other study available for hydralazine and Atrial Septal Defect
| Article | Year |
|---|---|
Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large atrial septal defects.
Topics: Blood Pressure; Heart Failure; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hydralazine; Isos | 1982 |